Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
G5-K Solution is a balanced crystalloid intravenous fluid used for perioperative fluid management. It is a glucose 5%/potassium-based balanced solution, containing sodium (50.0 mmol/l), potassium (30.0 mmol/l), magnesium (2.0 mmol/l), chloride (65 mmol/l), lactate (18 mmol/l), phosphate (8.0 mmol/l), and glucose (50 g/l). Notably, it contains no calcium or acetate. Unlike many standard crystalloids, it is designed to avoid supraphysiologic chloride loading, with the goal of achieving near-zero water and salt balance perioperatively. It was studied in the context of bladder cancer—specifically in adult patients undergoing open radical cystectomy with urinary diversion—in an investigator-initiated, single-center, randomized controlled trial at Bern University Hospital (Inselspital), Switzerland. The trial compared G5-K solution against Ringerfundin (Ringer's maleate) as a baseline perioperative infusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on G5-K solution.